Longevity science

A new study demonstrates what researchers consider conclusive evidence that the red wine compound resveratrol directly activates a protein that promotes health and longevity in animal models.

What’s more, the researchers have uncovered the molecular mechanism for this interaction, and show that a class of more potent drugs currently in clinical trials act in a similar fashion. Pharmaceutical compounds similar to resveratrol may potentially treat and prevent diseases related to aging in people, the authors contend.

Researchers from Purdue University in Indiana are testing a compound found in red wine that has the ability to block the processes of fat cell development. The research into the compound known as piceatannol may lead towards finding a simple method to combat obesity.

Piceatannol results from the conversion of resveratrol – a compound found in red wine, grapes and peanuts that is also thought to combat cancer, heart disease and neurodegenerative diseases. When resveratrol is converted into the piceatannol

Metabolites from the break-down of resveratrol have been shown to come together and regenerate the compound inside living cells, leaving researchers questioning whether worries over bioavailability are relevant.

University of Leicester scientists have presented groundbreaking new evidence about how a chemical found in red wine can help prevent cancer.

Experts from around the world attended Resveratrol 2012, a major conference at the University to assess the latest advances in the study of resveratrol — a compound found in the skins of red grapes.

A recent study supported existing research that moderate wine intake supports healthy lung function. The researchers found an association between resveratrol intake and higher lung volumes, as well as white wine intake and lower risk of airway obstruction.